Larimar Therapeutics
LRMR
#6469
Rank
NZ$0.97 B
Marketcap
$15.24
Share price
-2.69%
Change (1 day)
275.77%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.53

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.55. In 2022 the company made an earnings per share (EPS) of -$2.60 an increase over its 2021 EPS that were of -$5.01.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.53-41.15%
2022-$2.60-48.15%
2021-$5.01-14.27%
2020-$5.84